Back to ATNM

Actinium Pharmaceuticals, Inc. 10-K

Accession 0001213900-26-036504

Filing information

CIK
0001388320
Report date
2025-12-31
Filing date
2026-03-30
Form
10-K
Primary document
ea0279291-10k_actinium.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.